ICB Pharma is a Polish family-owned research and innovation company founded in 2000, specializing in advanced preparations across healthcare, sanitary hygiene, and environmental protection. It was established through the merger of ICB Polska and Pest Control News, both operated by the Świętosławski family — and from its earliest years in production, the company built its competitive edge on proprietary, patent-protected formulations. Over more than a quarter century, ICB Pharma has steadily expanded its laboratory infrastructure and innovation portfolio, becoming one of the most recognized Polish chemical brands in Europe and beyond. The Forbes Diamonds 2023 award, given to the most dynamic private companies in Poland, stands as clear testimony to the position ICB Pharma has earned on the European chemical industry map.
Company History and Structure
ICB Pharma was officially registered as a general partnership in 2003, though production operations launched in October 2000. Export expansion was a core priority from day one — today the company's products reach more than 90 countries across six continents. Three modern research laboratories, staffed daily by chemists and biologists, continuously develop new formulations and verify product efficacy through rigorous testing. The company operates an accredited analytical laboratory conducting physicochemical quality testing, and holds medical device manufacturer status — an obligation that demands exceptionally high standards in documentation, process control, and method validation. A portfolio of over 180 products and numerous patents reflects the scale of that ongoing work.
Nano- and Microencapsulation Technology
ICB Pharma's most significant technological advantage is its mastery of nano- and microencapsulation technology, which enables precise delivery of active substances at the right location and time. As a result, preparations work longer and more effectively at lower active ingredient concentrations, while minimizing the burden on the human body and the environment. This technology is applied, among other areas, in the insect and arachnid repellent series, where it enables the development of long-lasting protective formulations. The company's in-house analytical laboratory conducts detailed testing to confirm that every production batch meets European and international standards.
Main Product Lines
ICB Pharma's operations are organized around four segments. Health Care covers preparations for head lice treatment (Pipi Nitolic series), house dust allergen neutralization (Allergoff and Allergoff Atopy series for atopic skin), and protection against ticks, mosquitoes, and blackflies (Kick The Tick series). For outdoor-active users, the Kick The Tick series is of particular relevance: repellents, accessories for safe tick removal, and preventive agents — practical solutions for hikers, hunters, anglers, trail runners, and anyone who regularly spends time in forests or fields. Animal Health delivers solutions for the health of both companion and farm animals. Pest Innovations covers professional products for the pest control and disinsection sector. Crop Solutions offers preparations for sustainable agriculture and horticulture.
ICB Pharma at Militaria.pl
At Militaria.pl you'll find a carefully selected range of ICB Pharma products aimed at active users operating in the field. The assortment focuses primarily on the Kick The Tick series — repellents and tick removal accessories essential during trekking, camping, and all outdoor activities. Allergoff series products for allergy sufferers and those sensitive to house dust mites are also available. Choosing ICB Pharma means trusting Polish know-how, scientifically validated efficacy backed by in-house research capabilities, and products that meet rigorous European safety and quality standards.
